Reading SONM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SONM free→Reading SONM? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track SONM free→QuarterlyIQ Insights · SONM
Material updates from SEC filings (8-K, 10-Q, 10-K) ranked by impact, with no firehose noise.
Termination of a Material Definitive Agreement. As previously disclosed, on September 29, 2025, DNA X, Inc. (the “Company”) and Chardan Capital Markets LLC (“Chardan”) entered into a ChEF Purchase Agreement (the “ChEF Agreement”) pursuant to which Chardan committed to purchase, subject to certain limitations and conditions set forth in the ChEF Agreement, up to $500 million of shares of the Company’s common stock, par value $0.001 per share, and a Registration Rights Agreement (the “Registrat…
Entry Into a Material Definitive Agreement. Securities Purchase Agreement; Issuance of Convertible Note On May 20, 2026, DNA X, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with DNA Holdings Venture, Inc. (the “Purchaser”) pursuant to which the Company sold and issued to the Purchaser a convertible promissory note (the “Note”) in the principal amount of $3,052,787.68 for an aggregate purchase price in the same amount. The transactions contemplat…
Creation of a Direct Financial Obligation or an Obligation under an Off-Balane Sheet Arrangement of a Registrant. The information set forth in
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on August 22, 2025, the Company received a letter from the staff of the Nasdaq Listing Qualifications Department (the “Staff”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity Requirement…
The Note was issued in reliance upon the exemption from registration afforded by Section 4(a)(2) of the Securities Act and/or Rule 506(b) of Regulation D promulgated under the Securities Act. The Purchaser has represented to the Company that it is an “accredited investor” as defined in Rule 501(a) under the Securities Act. The Purchaser has represented that it is acquiring the Note as principal for its own account and not with a view to or for distributing or reselling the Note or any part th…
Results of Operations and Financial Condition. On May 20, 2026, DNA X, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026 (the “Press Release”). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Changes in Registrant’s Certifying Accountant. Dismissal of Independent Registered Public Accounting Firm On April 27, 2026, the Audit Committee of the Board of Directors (the “Audit Committee”) of DNA X, Inc. (the “Company”) dismissed Baker Tilly US, LLP (“Baker Tilly”) as the Company’s independent registered public accounting firm. Baker Tilly’s audit reports on the Company’s consolidated financial statements for the fiscal years ended December 31, 2025 and December 31, 2024 did not contain…
Results of Operations and Financial Condition. On April 14, 2026, DNA X, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended December 31, 2025 (the “Press Release”). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Material Modification to Rights of Security Holders. The information contained above under the heading “ Convertible Promissory Note ” in
Entry into a Material Definitive Agreement. Note Offering and Purchase of Membership Interest On December 15, 2025, Sonim Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with DNA Holdings Venture, Inc. (“DNA Holdings”) and issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”), in a private placement (the “Offering”). The Company paid no placement agent fees in connection with the Offering…
Unregistered Sales of Equity Securities. The information contained above under the headings “ Membership Interest Purchase Agreement ” and “ Exchange Agreement ” in
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained above under the heading “ Note Offering and Purchase of Membership Interest ” in
Completion of Acquisition or Disposition of Assets. The information contained above under the heading “ Note Offering and Purchase of Membership Interest ” in
Material Modification to Rights of Security Holders. The information contained above under the heading “ Convertible Promissory Note ” in
Completion of Acquisition or Disposition of Assets. The information contained above under the heading “ Note Offering and Purchase of Membership Interest ” in
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained above under the heading “ Note Offering and Purchase of Membership Interest ” in
Entry into a Material Definitive Agreement. Note Offering and Purchase of Membership Interest On December 15, 2025, Sonim Technologies, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with DNA Holdings Venture, Inc. (“DNA Holdings”) and issued a convertible promissory note in the original principal amount of $1,200,000 (the “DNA Note”), in a private placement (the “Offering”). The Company paid no placement agent fees in connection with the Offering…
Unregistered Sales of Equity Securities. The information contained above under the headings “ Membership Interest Purchase Agreement ” and “ Exchange Agreement ” in
The foregoing summary of the Asset Purchase Agreement and transactions contemplated thereby does not purport to be complete and is qualified in its entirety by the full text of the Asset Purchase Agreement, a copy of which is available as follows: (i) Annex A and Annex B of the Company’s definitive proxy statement filed with the Securities and Exchange Commission (the “ SEC ”) on December 5, 2025; and (ii) Exhibit 2.1 of this Current Report.
Entry into a Material Definitive Agreement. On the Closing Date, the Company, the Buyer, the Parent, and the Seller Representative entered into a second amendment to the Asset Purchase Agreement (the “ APA Amendment ”). The APA Amendment modifies certain provisions of the Asset Purchase Agreement, including: ● replacing the escrow arrangement contemplated by the Asset Purchase Agreement with a $1.5 million holdback amount (the “holdback amount”) to be retained by the Buyer at the closing as a…
Termination of a Material Definitive Agreement. On the Closing Date, the Company prepaid (i) that certain promissory note (the “ July Note ”), dated July 11, 2025, issued by the Company to Streeterville Capital, LLC (the “ Lender ”), pursuant to that certain note purchase agreement, dated July 11, 2025, by and between the Company and the Lender and (ii) that certain promissory note (the “ February Note ” and, together with the July Note, the “ Notes ”), dated February 21, 2025, issued by the…
Material Modification to Rights of Security Holders. The information contained above under the heading “ Convertible Promissory Note ” in
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant. The information contained above under the heading “ Note Offering and Purchase of Membership Interest ” in
Completion of Acquisition or Disposition of Assets. The information contained above under the heading “ Note Offering and Purchase of Membership Interest ” in
Unregistered Sales of Equity Securities. The information contained above under the headings “ Membership Interest Purchase Agreement ” and “ Exchange Agreement ” in
General market headlines, full earnings-call transcripts, and macro and sector developments flagged when they directly affect this stock are on the way. Today this tab covers SEC filings.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.